Influence of Erroneous Patient Records on Population Pharmacokinetic Modeling and Individual Bayesian Estimation

被引:9
|
作者
van der Meer, Aize Franciscus [1 ]
Touw, Daniel J. [2 ]
Marcus, Marco A. E. [1 ]
Neef, Cornelis [3 ]
Proost, Johannes H. [4 ]
机构
[1] Maastricht Univ, Med Ctr, Dept Anesthesiol, NL-6202 AZ Maastricht, Netherlands
[2] Cent Hosp Pharm, The Hague, Netherlands
[3] Maastricht Univ, Med Ctr, Dept Clin Pharm, NL-6202 AZ Maastricht, Netherlands
[4] Univ Groningen, Univ Ctr Pharm, Dept Pharmacokinet Toxicol & Targeting, Groningen, Netherlands
关键词
maximum a posteriori Bayesian estimation; pharmacokinetics; population modeling; patient records; error identification; PERFORMANCE; VANCOMYCIN; SIMULATION;
D O I
10.1097/FTD.0b013e3182616937
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Observational data sets can be used for population pharmacokinetic (PK) modeling. However, these data sets are generally less precisely recorded than experimental data sets. This article aims to investigate the influence of erroneous records on population PK modeling and individual maximum a posteriori Bayesian (MAPB) estimation. Methods: A total of 1123 patient records of neonates who were administered vancomycin were used for population PK modeling by iterative 2-stage Bayesian (ITSB) analysis. Cut-off values for weighted residuals were tested for exclusion of records from the analysis. A simulation study was performed to assess the influence of erroneous records on population modeling and individual MAPB estimation. Also the cut-off values for weighted residuals were tested in the simulation study. Results: Errors in registration have limited the influence on outcomes of population PK modeling but can have detrimental effects on individual MAPB estimation. A population PK model created from a data set with many registration errors has little influence on subsequent MAPB estimates for precisely recorded data. A weighted residual value of 2 for concentration measurements has good discriminative power for identification of erroneous records. Conclusions: ITSB analysis and its individual estimates are hardly affected by most registration errors. Large registration errors can be detected by weighted residuals of concentration.
引用
收藏
页码:526 / 534
页数:9
相关论文
共 50 条
  • [31] Bayesian estimation of a cancer population by capture-recapture with individual capture heterogeneity and small sample
    Bailly, Laurent
    Daures, Jean Pierre
    Dunais, Brigitte
    Pradier, Christian
    BMC MEDICAL RESEARCH METHODOLOGY, 2015, 15
  • [32] To antidote or not? Population Pharmacokinetic Modeling and Bayesian Forecasting as a Tool to Predict the Need for Antidote in Acute Acetaminophen Overdose
    Desrochers, Julie
    Klein-Schwartz, Wendy
    Doyon, Suzanne
    Gobburu, Joga
    Gopalakrishnan, Mathangi
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2015, 42 : S96 - S96
  • [33] Population pharmacokinetic/pharmacogenetic modeling and design of a bayesian estimator for the therapeutic drug monitoring of tacrolimus in lung transplantation
    Monchaud, C.
    De Winter, B.
    Estenne, M.
    Reynaud-Gaubert, M.
    Pison, C.
    Stern, M.
    Kessler, R.
    Guillemain, R.
    Marquet, P.
    Rousseau, A.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2011, 25 : 54 - 54
  • [34] POPULATION PHARMACOKINETIC MODELING AND BAYESIAN ESTIMATORS FOR THERAPEUTIC DRUG MONITORING OF PYRAZINAMIDE IN KOREAN TUBERCULOSIS PATIENTS.
    Choi, Y. -K.
    Kim, D. -H.
    Lee, H. -K.
    Kim, H.
    Kim, D. -Y.
    Kim, D.
    Shin, J. -G.
    Ghim, J. -L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S90 - S90
  • [36] Augmented renal clearance of aminoglycosides using population-based pharmacokinetic modelling with Bayesian estimation in the paediatric ICU
    Avedissian, Sean N.
    Rhodes, Nathaniel J.
    Kim, Yuna
    Bradley, John
    Valdez, Joshua L.
    Le, Jennifer
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2020, 75 (01) : 162 - 169
  • [37] Utility of "trough levels" adalimumab determination in patients with inflammatory bowel disease. Estimation of individual pharmacokinetic parameters through population pharmacokinetic model
    Juan, G.
    Alvarino, A.
    Mora, M.
    Oltra, L.
    Maroto, N.
    Ferrer, I.
    Hinojosa, E.
    Hinojosa, M. D.
    Hinojosa, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S363 - S364
  • [38] Modeling population dynamics under the influence of harmful substances on the individual reproduction process
    N. V. Pertsev
    G. E. Tsaregorodtseva
    Automation and Remote Control, 2011, 72 : 129 - 140
  • [39] Modeling population dynamics under the influence of harmful substances on the individual reproduction process
    Pertsev, N. V.
    Tsaregorodtseva, G. E.
    AUTOMATION AND REMOTE CONTROL, 2011, 72 (01) : 129 - 140
  • [40] Sparse Bayesian modeling of hierarchical independent component analysis: Reliable estimation of individual differences in brain networks
    Lukemire, Joshua
    Pagnoni, Giuseppe
    Guo, Ying
    BIOMETRICS, 2023, 79 (04) : 3599 - 3611